Back

Long-term outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy

27 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Cardiomyopathies: diagnosis and outcome Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Fang Liu

Beijing Anzhen Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Relation of national economic status to diagnostic and management characteristics of patients with hypertrophic cardiomyopathy in the EORP cardiomyopathy registry of the european society of cardiology
Doctor R. Jurcut (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Baseline characteristics of the hypertrophic cardiomyopathy registry (n=2773)
Doctor S. Neubauer (Oxford, GB)
Abstract Slides
Presentation thumbnail
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy
Doctor N. Maurizi (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Progression of cardiomyopathy in patients with muscular dystrophy - a CMR-based extensive follow-up study
Doctor A. Florian (Berlin, DE)
Abstract Slides
Presentation thumbnail
Clinical characteristics and natural history of dilated cardiomyopathy due to BAG3 mutations.
Doctor F. Dominguez (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Cardiomyopathies: diagnosis and outcome

The Event

Event poster

ESC Congress 2018

27 August 2018 10:05 CET
You may be interested in
thumbnail
Congress Presentation
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Presentation
Long term outcome after a first myocardial infarction
27 August 2021
thumbnail
Congress Presentation
Genetic influences on clinical outcomes in hypertrophic cardiomyopathy: comparative insights into MYH7, MYBPC3 and TPM1 gene mutations
18 May 2025
thumbnail
Congress Presentation
Impact of gastrointestinal hemorrhage on hospital outcomes of patients with hypertrophic cardiomyopathy
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources